| A minimum dataset for a standard adult transthoracic echocardiogram: a guideline protocol from the British Society of Echocardiography G Wharton, R Steeds, J Allen, H Phillips, R Jones, P Kanagala, G Lloyd, ... Echo Research & Practice 2 (1), G9-G24, 2015 | 208 | 2015 |
| Comparison of cardiovascular magnetic resonance feature tracking and tagging for the assessment of left ventricular systolic strain in acute myocardial infarction JN Khan, A Singh, SA Nazir, P Kanagala, AH Gershlick, GP McCann European journal of radiology 84 (5), 840-848, 2015 | 149 | 2015 |
| Relationship between focal and diffuse fibrosis assessed by CMR and clinical outcomes in heart failure with preserved ejection fraction P Kanagala, ASH Cheng, A Singh, JN Khan, GS Gulsin, P Patel, P Gupta, ... JACC: Cardiovascular Imaging 12 (11 Part 2), 2291-2301, 2019 | 99 | 2019 |
| Intertechnique agreement and interstudy reproducibility of strain and diastolic strain rate at 1.5 and 3 tesla: A comparison of feature‐tracking and tagging in patients with … A Singh, CD Steadman, JN Khan, MA Horsfield, S Bekele, SA Nazir, ... Journal of Magnetic Resonance Imaging 41 (4), 1129-1137, 2015 | 86 | 2015 |
| Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction–implications for clinical trials P Kanagala, ASH Cheng, A Singh, J McAdam, AM Marsh, JR Arnold, ... Journal of cardiovascular magnetic resonance 20 (1), 4, 2018 | 74 | 2018 |
| Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction P Kanagala, JR Arnold, ASH Cheng, A Singh, JN Khan, GS Gulsin, ... The international journal of cardiovascular imaging 36, 101-110, 2020 | 43 | 2020 |
| Characterizing heart failure with preserved and reduced ejection fraction: an imaging and plasma biomarker approach P Kanagala, JR Arnold, A Singh, DCS Chan, ASH Cheng, JN Khan, ... PloS one 15 (4), e0232280, 2020 | 42 | 2020 |
| Combined use of trimethylamine N-oxide with BNP for risk stratification in heart failure with preserved ejection fraction: findings from the DIAMONDHFpEF study A Salzano, MZ Israr, Y Yazaki, LM Heaney, P Kanagala, A Singh, ... European journal of preventive cardiology 27 (19), 2159-2162, 2020 | 41 | 2020 |
| Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis M Chowdhury, S Nevitt, A Eleftheriadou, P Kanagala, H Esa, ... BMJ Open Diabetes Research and Care 9 (2), e002480, 2021 | 40 | 2021 |
| Guidelines for transoesophageal echocardiographic probe cleaning and disinfection from the British Society of Echocardiography, P Kanagala, C Bradley, P Hoffman, RP Steeds European journal of echocardiography 12 (10), i17-i23, 2011 | 39 | 2011 |
| Comparison of semi-automated methods to quantify infarct size and area at risk by cardiovascular magnetic resonance imaging at 1.5 T and 3.0 T field strengths JN Khan, SA Nazir, MA Horsfield, A Singh, P Kanagala, JP Greenwood, ... BMC research notes 8, 1-15, 2015 | 32 | 2015 |
| Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction. et al. Arnold JR, Kanagala P JACC Cardiovasc Imaging, 2022 | 31* | 2022 |
| Reproducibility of left atrial function using cardiac magnetic resonance imaging A Alfuhied, BA Marrow, S Elfawal, GS Gulsin, MP Graham-Brown, ... European Radiology 31, 2788-2797, 2021 | 25 | 2021 |
| Cardiac autonomic neuropathy in type 1 and 2 diabetes: epidemiology, pathophysiology, and management S Williams, SA Raheim, MI Khan, U Rubab, P Kanagala, SS Zhao, ... Clinical therapeutics 44 (10), 1394-1416, 2022 | 23 | 2022 |
| Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes GS Gulsin, P Kanagala, DCS Chan, ASH Cheng, L Athithan, ... Therapeutic advances in endocrinology and metabolism 10, 2042018819861593, 2019 | 21 | 2019 |
| Microvascular dysfunction in heart failure with preserved ejection fraction: Pathophysiology, assessment, prevalence and prognosis JM Bilak, U Alam, CA Miller, GP McCann, JR Arnold, P Kanagala Cardiac failure review 8, 2022 | 20 | 2022 |
| Current outcome of heart transplantation: a 10-year single centre perspective and review IM Hamour, A Khaghani, PK Kanagala, AG Mitchell, NR Banner QJM: An International Journal of Medicine 104 (4), 335-343, 2011 | 20 | 2011 |
| Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction P Kanagala, JR Arnold, A Singh, JN Khan, GS Gulsin, P Gupta, IB Squire, ... The International Journal of Cardiovascular Imaging 37, 255-266, 2021 | 18 | 2021 |
| Plasma Tenascin-C: a prognostic biomarker in heart failure with preserved ejection fraction P Kanagala, JR Arnold, JN Khan, A Singh, GS Gulsin, DCS Chan, ... Biomarkers 25 (7), 556-565, 2020 | 18 | 2020 |
| Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART—a UK, multicentre, observational study M Gorecka, GP McCann, C Berry, VM Ferreira, JC Moon, CA Miller, ... Journal of Cardiovascular Magnetic Resonance 23 (1), 77, 2021 | 17 | 2021 |
